by: xpoolPosted on:

Injective Reaches New High, Institutional ETF Filings Expected to Unlock Trillions in Capital

Injective (INJ) has shown strength by reclaiming $9 support within its long-term trading range. This comes as institutional investors are actively exploring the potential of exchange-traded funds (ETFs), a move that could unlock trillions of dollars previously locked away. 📈 💸 RWA and GPU markets suggest Injective’s infrastructure role is expanding.

Related posts:

  1. Canary Capital Registers Staked Injective ETF in Delaware
  2. Canary Capital Prepares For Injective-Based ETF Launch in US
  3. ETF Issuers Urge SEC to Reinstate First-To-File System
  4. Crypto ETF Issuers Demand First-to-File Rule for Market Fairness